GLENMARK PHARMACEUTICALS
|
GLENMARK PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹1,399 Cr | ₹569 Cr | ₹868 Cr | ₹1,441 Cr | ₹1,382 Cr |
| Adjustment | ₹982 Cr | ₹1,010 Cr | ₹1,472 Cr | ₹787 Cr | ₹645 Cr |
| Changes In working Capital | ₹-2,529 Cr | ₹-797 Cr | ₹-1,074 Cr | ₹-561 Cr | ₹-386 Cr |
| Cash Flow after changes in Working Capital | ₹-147 Cr | ₹782 Cr | ₹1,266 Cr | ₹1,667 Cr | ₹1,641 Cr |
| Cash Flow from Operating Activities | ₹-828 Cr | ₹-265 Cr | ₹625 Cr | ₹1,109 Cr | ₹1,131 Cr |
| Cash Flow from Investing Activities | ₹2.09 Cr | ₹4,561 Cr | ₹-528 Cr | ₹-333 Cr | ₹-675 Cr |
| Cash Flow from Financing Activities | ₹787 Cr | ₹-3,906 Cr | ₹-77 Cr | ₹-520 Cr | ₹-442 Cr |
| Net Cash Inflow / Outflow | ₹-38 Cr | ₹389 Cr | ₹19 Cr | ₹255 Cr | ₹14 Cr |
| Opening Cash & Cash Equivalents | ₹1,658 Cr | ₹1,443 Cr | ₹1,411 Cr | ₹1,138 Cr | ₹1,110 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | ₹0.67 Cr | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | ₹-192 Cr | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹56 Cr | ₹18 Cr | ₹12 Cr | ₹18 Cr | ₹14 Cr |
| Closing Cash & Cash Equivalent | ₹1,676 Cr | ₹1,658 Cr | ₹1,443 Cr | ₹1,411 Cr | ₹1,138 Cr |
Compare Cashflow Statement of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,251.5 Cr | -0.5% | 5.3% | 43.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.5% |
5.3% |
43.5% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses